
|Podcasts|November 7, 2019
Episode 43: Pharma Reputation
Author(s)Christen Harm, Elaine Quilici
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
Advertisement
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Moving CAR-T Beyond Oncology
3
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
4
Navigating Complexity in Emerging Biotech: Innovations, Integrations, and Initial Hurdles
5

